Abstract
Objective: To evaluate the cardiovascular effects associated with the use of electronic cigarettes in young adults. Methods: An integrative literature review was conducted based on PubMed, using a structured search strategy. The initial search identified 242 items; After removing duplicates and applying two pre- defined eligibility criteria, 20 studies pre-enter the requirements for inclusion in the analysis. Results: The literature shows various pathophysiological mechanisms that cause electronic cigarettes to affect cardiovascular function. The studies indicate an increase in inflammatory markers, oxidative stress and greater thrombogenic potential, indicating systemic inflammatory activation and measured endothelial dysfunction. Experimental tests demonstrate alterations in arterial elasticity, vascular reactivity and myocardial performance, in addition to the presence of cardiotoxic metals in inhaled aerosols. Notably, non- nicotine formulations also produce significant vascular effects, suggesting that non-nicotinic chemicals play an important role in endothelial injury and oxidative response. Final considerations: The use of electronic cigarettes is associated with subclinical, early and potentially progressive vascular alterations, configuring a relevant cardiovascular risk profile comparable to that observed in conventional cigarette smokers. These points highlight the need for rigorous long-term studies to elucidate the progress of these alterations and measure their long-term impact.
References
ALAVI R, et al. Adverse cardiovascular effects of nicotine delivered by chronic electronic cigarettes or standard cigarettes captured by cardiovascular intrinsic frequencies. Journal of the American Heart Association, 2024; 13: e035462.
BEN TALEB Z, DABROY D. Pod-based e-cigarettes versus combustible cigarettes: The impact on peripheral and cerebral vascular function and subjective experiences. Tobacco Induced Diseases, 2023; 21: 71.
BIANCHI L, et al. Differential effects of traditional cigarette, electronic cigarette, and tobacco heating product on human vascular smooth muscle cell phenotypic switch: A comparative functional perspective. Atherosclerosis, 2025; 407(120412): 120412.
CHATTERJEE S, et al. Acute e-cig inhalation impacts vascular health: a study in smoking naïve subjects. American Journal of Physiology - Heart and Circulatory Physiology, 2021; 320(1): H144– H158.
DOROTHEO EU, et al. Nicotine and cardiovascular health: When poison is addictive – a WHF policy brief. Global Heart, 2024; 19(1): 14.
FRIED ND, GARDNER JD. Heat-not-burn tobacco products: an emerging threat to cardiovascular health. American Journal of Physiology - Heart and Circulatory Physiology, 2020; 319(6): H1234– H1239.
GENTZKE AS, et al. Tobacco product use among middle and high school students – United States, 2022. MMWR, 2022; 71(45): 1429–1435.
KAUR D, et al. Modulation of cardiovascular parameters and functional capacity after telephysiotherapeutic breathing yogic pranayam in young vapers in India. Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2024; 17(Suppl 1): S147–S153.
IKONOMIDIS I, et al. Differential effects of heat-not-burn and conventional cigarettes on coronary flow, myocardial and vascular function. Scientific Reports, 2021; 11:11808.
IKONOMIDIS I, et al. Effects of electronic cigarette on platelet and vascular function after four months of use. Food and Chemical Toxicology, 2020; 141:111389.
MATHESON C, et al. Evidence of premature vascular dysfunction in young adults who regularly use E-cigarettes and the impact of usage length. Physiology (Bethesda), 2024; 39(S1).
MÜNZEL T, et al. Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes. European Heart Journal, 2020; 41(41): 4057–4070.
MEARS MJ, et al. Electronic nicotine delivery systems and cardiovascular/cardiometabolic health.
Circulation Research, 2023; 132(9): 1168–1180.
NAVAS-ACIEN A, et al. Early cardiovascular risk in E-cigarette users: The potential role of metals.
Current Environmental Health Reports, 2020; 7(4): 353–361.
PODZOLKOV VI, et al. E-cigarette smoking (vaping) and markers of vascular wall damage in young subjects without cardiovascular disease. Rational Pharmacotherapy in Cardiology, 2021; 17(4): 521–527.
SAHOTA A, et al. Atherosclerosis inflammation and burden in young adult smokers and vapers measured by PET/MR. Atherosclerosis, 2021; 325: 110–116.
SCHOLZ JR, et al. Posicionamento da Sociedade Brasileira de Cardiologia sobre o Uso de Dispositivos Eletrônicos para Fumar – 2024. Arquivos Brasileiros de Cardiologia, 2024; 121(2): e20240063.
LYYTINEN G, et al. Electronic cigarette vaping with nicotine causes increased thrombogenicity and impaired microvascular function in healthy volunteers: A randomised clinical trial. Cardiovascular Toxicology, 2023; 23(7–8): 255–264.
TARRAN R, et al. E-cigarettes and cardiopulmonary health. Function, 2021; 2(2): zqab004.
WEHRLI FW, et al. New insights from MRI and cell biology into the acute vascular-metabolic implications of electronic cigarette vaping. Frontiers in Physiology, 2020; 11: 492.
ZOCCAI G, et al. Electronic cigarette. European Society of Cardiology, 2020; 22(Suppl E): E25– E29.
